Related references
Note: Only part of the references are listed.Aristolochic acid exposure in Romania and implications for renal cell carcinoma
Robert J. Turesky et al.
BRITISH JOURNAL OF CANCER (2016)
Sulfotransferase-1A1-dependent bioactivation of aristolochic acid I and N-hydroxyaristolactam I in human cells
Keiji Hashimoto et al.
CARCINOGENESIS (2016)
Induction of cytochromes P450 1A1 and 1A2 suppresses formation of DNA adducts by carcinogenic aristolochic acid I in rats in vivo
Helena Dracinska et al.
TOXICOLOGY (2016)
Preventing Aristolochic Acid Nephropathy
Nelomi Anandagoda et al.
CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2015)
Balkan nephropathy
Vladisav Stefanovic et al.
CLINICAL NEPHROLOGY (2015)
A Mechanism of O-Demethylation of Aristolochic Acid I by Cytochromes P450 and Their Contributions to This Reaction in Human and Rat Livers: Experimental and Theoretical Approaches
Marie Stiborova et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2015)
New approaches for biomonitoring exposure to the human carcinogen aristolochic acid
Byeong Hwa Yun et al.
TOXICOLOGY RESEARCH (2015)
The influence of ochratoxin A on DNA adduct formation by the carcinogen aristolochic acid in rats
Marie Stiborova et al.
ARCHIVES OF TOXICOLOGY (2015)
Bioactivation of the human carcinogen aristolochic acid
Viktoriya S. Sidorenko et al.
CARCINOGENESIS (2014)
Determination of Sulfotransferase Forms Involved in the Metabolic Activation of the Genotoxicant 1-Hydroxymethylpyrene Using Bacterially Expressed Enzymes and Genetically Modified Mouse Models
Carolin Bendadani et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2014)
Update on endemic nephropathies
Annika Wernerson et al.
CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION (2014)
Organic compounds in water extracts of coal: links to Balkan endemic nephropathy
S. V. M. Maharaj et al.
ENVIRONMENTAL GEOCHEMISTRY AND HEALTH (2014)
Exceptionally long- term persistence of DNA adducts formed by carcinogenic aristolochic acid I in renal tissue from patients with aristolochic acid nephropathy
Heinz H. Schmeiser et al.
INTERNATIONAL JOURNAL OF CANCER (2014)
Mechanisms of Enzyme-Catalyzed Reduction of Two Carcinogenic Nitro-Aromatics, 3-Nitrobenzanthrone and Aristolochic Acid I: Experimental and Theoretical Approaches
Marie Stiborova et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
Limitations and plausibility of the Pliocene lignite hypothesis in explaining the etiology of Balkan endemic nephropathy
S. V. M. Maharaj
INTERNATIONAL JOURNAL OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH (2014)
The influence of dicoumarol on the bioactivation of the carcinogen aristolochic acid I in rats
Marie Stiborova et al.
MUTAGENESIS (2014)
The effect of aristolochic acid I on expression of NAD(P)H:quinone oxidoreductase in mice and rats-A comparative study
Frantisek Barta et al.
MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS (2014)
Consensus statement on screening, diagnosis, classification and treatment of endemic (Balkan) nephropathy
Bojan Jelakovic et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2014)
Unambiguous Detection of Multiple TP53 Gene Mutations in AAN-Associated Urothelial Cancer in Belgium Using Laser Capture Microdissection
Selda Aydin et al.
PLOS ONE (2014)
Global and specific histone acetylation pattern in patients with Balkan endemic nephropathy, a worldwide disease
Gordana Kocic et al.
RENAL FAILURE (2014)
Evaluating Weight of Evidence in the Mystery of Balkan Endemic Nephropathy
Travis Bui-Klimke et al.
RISK ANALYSIS (2014)
Knockout and humanized mice as suitable tools to identify enzymes metabolizing the human carcinogen aristolochic acid
Marie Stiborova et al.
XENOBIOTICA (2014)
Variation in genomic landscape of clear cell renal cell carcinoma across Europe
Ghislaine Scelo et al.
NATURE COMMUNICATIONS (2014)
Modelling mutational landscapes of human cancers in vitro
Magali Olivier et al.
SCIENTIFIC REPORTS (2014)
Is Increased Susceptibility to Balkan Endemic Nephropathy in Carriers of Common GSTA1 (*A/*B) Polymorphism Linked with the Catalytic Role of GSTA1 in Ochratoxin A Biotransformation? Serbian Case Control Study and In Silico Analysis
Zorica Reljic et al.
TOXINS (2014)
NGS Nominated CELA1, HSPG2, and KCNK5 as Candidate Genes for Predisposition to Balkan Endemic Nephropathy
D. Toncheva et al.
BIOMED RESEARCH INTERNATIONAL (2014)
Human Formalin-Fixed Paraffin-Embedded Tissues: An Untapped Specimen for Biomonitoring of Carcinogen DNA Adducts by Mass Spectrometry
Byeong Hwa Yun et al.
ANALYTICAL CHEMISTRY (2013)
The Epidemiology, Diagnosis, and Management of Aristolochic Acid Nephropathy A Narrative Review
M. Refik Goekmen et al.
ANNALS OF INTERNAL MEDICINE (2013)
Induced Expression of Cytochrome P450 1A and NAD(P)H:Quinone Oxidoreductase Determined at mRNA, Protein, and Enzyme Activity Levels in Rats Exposed to the Carcinogenic Azo Dye 1-Phenylazo-2-naphthol (Sudan I)
Marie Stiborova et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2013)
Enzymes Metabolizing Aristolochic Acid and their Contribution to the Development of Aristolochic Acid Nephropathy and Urothelial Cancer
Marie Stiborova et al.
CURRENT DRUG METABOLISM (2013)
Aristolochic acid nephropathy: Harbinger of a global iatrogenic disease
Arthur P. Grollman
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS (2013)
Genome-Wide Mutational Signatures of Aristolochic Acid and Its Application as a Screening Tool
Song Ling Poon et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Mutational Signature of Aristolochic Acid Exposure as Revealed by Whole-Exome Sequencing
Margaret L. Hoang et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Whole genome methylation array analysis reveals new aspects in Balkan endemic nephropathy etiology
Rada Staneva et al.
BMC NEPHROLOGY (2013)
Balkan endemic nephropathy-current status and future perspectives
Nikola M. Pavlovic
CLINICAL KIDNEY JOURNAL (2013)
An Update on Direct Genotoxicity as a Molecular Mechanism of Ochratoxin A Carcinogenicity
Annie Pfohl-Leszkowicz et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2012)
Biomonitoring of Aristolactam-DNA Adducts in Human Tissues Using Ultra-Performance Liquid Chromatography/Ion-Trap Mass Spectrometry
Byeong Hwa Yun et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2012)
ACB-PCR measurement of H-ras codon 61 CAA→CTA mutation provides an early indication of aristolochic acid I carcinogenic effect in tumor target tissues
Yiying Wang et al.
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS (2012)
Evidence of exposure to aristolochic acid in patients with urothelial cancer from a Balkan endemic nephropathy region of Romania
Heinz H. Schmeiser et al.
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS (2012)
Glutathione S-transferases T1 null genotype is associated with susceptibility to aristolochic acid nephropathy
Bicheng Chen et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2012)
Aristolactam-DNA adducts are a biomarker of environmental exposure to aristolochic acid
Bojan Jelakovic et al.
KIDNEY INTERNATIONAL (2012)
Chinese herbs nephropathy and Balkan endemic nephropathy: toward a single entity, aristolochic acid nephropathy
Marc E. De Broe
KIDNEY INTERNATIONAL (2012)
Lack of recognition by global-genome nucleotide excision repair accounts for the high mutagenicity and persistence of aristolactam-DNA adducts
Victoria S. Sidorenko et al.
NUCLEIC ACIDS RESEARCH (2012)
Aristolochic acid-associated urothelial cancer in Taiwan
Chung-Hsin Chen et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Bioactivation versus Detoxication of the Urothelial Carcinogen Aristolochic Acid I by Human Cytochrome P450 1A1 and 1A2
Marie Stiborova et al.
TOXICOLOGICAL SCIENCES (2012)
NAD(P)H:quinone oxidoreductase expression in Cyp1a-knockout and CYP1A-humanized mouse lines and its effect on bioactivation of the carcinogen aristolochic acid I
Katerina Levova et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2012)
Endoplasmic reticulum stress mediates aristolochic acid I-induced apoptosis in human renal proximal tubular epithelial cells
Shaohua Zhu et al.
TOXICOLOGY IN VITRO (2012)
Role of P450 1A1 and P450 1A2 in Bioactivation versus Detoxication of the Renal Carcinogen Aristolochic Acid I: Studies in Cyp1a1(-/-), Cyp1a2(-/-), and Cyp1a1/1a2(-/-) Mice
Volker M. Arlt et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2011)
The Human Carcinogen Aristolochic Acid I Is Activated to Form DNA Adducts by Human NAD(P)H:quinone Oxidoreductase Without the Contribution of Acetyltransferases or Sulfotransferases
Marie Stiborova et al.
ENVIRONMENTAL AND MOLECULAR MUTAGENESIS (2011)
Gene expression changes induced by the human carcinogen aristolochic acid I in renal and hepatic tissue of mice
Volker M. Arlt et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
TP53 Mutational signature for aristolochic acid: an environmental carcinogen
Masaaki Moriya et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Aristolochic acid-induced carcinogenesis examined by ACB-PCR quantification of H-Ras and K-Ras mutant fraction
Yiying Wang et al.
MUTAGENESIS (2011)
Role of Cytochromes P450 1A1/2 in Detoxication and Activation of Carcinogenic Aristolochic Acid I: Studies with the Hepatic NADPH:Cytochrome P450 Reductase Null (HRN) Mouse Model
Katerina Levova et al.
TOXICOLOGICAL SCIENCES (2011)
Inhibition of Renal NQO1 Activity by Dicoumarol Suppresses Nitroreduction of Aristolochic Acid I and Attenuates its Nephrotoxicity
Min Chen et al.
TOXICOLOGICAL SCIENCES (2011)
Aristolochic acid I induced oxidative DNA damage associated with glutathione depletion and ERK1/2 activation in human cells
Feng-Yih Yu et al.
TOXICOLOGY IN VITRO (2011)
Structures of Covalent Adducts between DNA and Ochratoxin A: A New Factor in Debate about Genotoxicity and Human Risk Assessment
Peter G. Mantle et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2010)
Cytochrome P450 1A2 Detoxicates Aristolochic Acid in the Mouse
Thomas A. Rosenquist et al.
DRUG METABOLISM AND DISPOSITION (2010)
Linking environmental carcinogen exposure to TP53 mutations in human tumours using the human TP53 knock-in (Hupki) mouse model
Jill E. Kucab et al.
FEBS JOURNAL (2010)
Detoxification of aristolochic acid I by O-demethylation: less nephrotoxicity and genotoxicity of aristolochic acid Ia in rodents
Shinya Shibutani et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
Toxicities of aristolochic acid I and aristololactam I in cultured renal epithelial cells
Ji Li et al.
TOXICOLOGY IN VITRO (2010)
OCHRATOXIN A AND ARISTOLOCHIC ACID INVOLVEMENT IN NEPHROPATHIES AND ASSOCIATED UROTHELIAL TRACT TUMOURS
Annie Pfohl-Leszkowicz
ARHIV ZA HIGIJENU RADA I TOKSIKOLOGIJU-ARCHIVES OF INDUSTRIAL HYGIENE AND TOXICOLOGY (2009)
THE ROLE OF BIOTRANSFORMATION ENZYMES IN THE DEVELOPMENT OF RENAL INJURY AND UROTHELIAL CANCER CAUSED BY ARISTOLOCHIC ACID: URGENT QUESTIONS AND DIFFICULT ANSWERS
Marie Stiborova et al.
BIOMEDICAL PAPERS-OLOMOUC (2009)
Genetic Polymorphism of the Human Cytochrome P450 2C9 Gene and Its Clinical Significance
Bo Wang et al.
CURRENT DRUG METABOLISM (2009)
TP53 mutation signature supports involvement of aristolochic acid in the aetiology of endemic nephropathy-associated tumours
Tatiana Nedelko et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Local uses of Aristolochia species and content of nephrotoxic aristolochic acid 1 and 2-A global assessment based on bibliographic sources
Michael Heinrich et al.
JOURNAL OF ETHNOPHARMACOLOGY (2009)
Mycotoxins and the kidney: Modes of action for renal tumor formation by ochratoxin A in rodents
Angela Mally et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2009)
Upper urothelial carcinoma in Balkan endemic nephropathy and non-endemic regions: A comparative study of pathological features
Ljubinka Jankovic Velickovic et al.
PATHOLOGY RESEARCH AND PRACTICE (2009)
Fifty Years of Balkan Endemic Nephropathy: Challenges of Study Using Epidemiological Method
Vladisav Stefanovic et al.
RENAL FAILURE (2009)
Balkan nephropathy: Evolution of our knowledge
Giorgos Bamias et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2008)
Metals and kidney markers in adult offspring of endemic nephropathy patients and controls: a two-year follow-up study
Wilfried Karmaus et al.
ENVIRONMENTAL HEALTH (2008)
Hepatic cytochrome P450s metabolize aristolochic acid and reduce its kidney toxicity
Y Xiao et al.
KIDNEY INTERNATIONAL (2008)
Biotransformation enzymes in development of renal injury and urothelial cancer caused by aristolochic acid
M. Stiborova et al.
KIDNEY INTERNATIONAL (2008)
Aristolochic acid nephropathy: A worldwide problem
Frederic D. Debelle et al.
KIDNEY INTERNATIONAL (2008)
Metabolic activation of carcinogenic aristolochic acid, a risk factor for Balkan endemic nephropathy
Marie Stiborova et al.
MUTATION RESEARCH-REVIEWS IN MUTATION RESEARCH (2008)
Induction of P450 1A by 3-methylcholanthrene protects mice from aristolochic acid-I-induced acute renal injury
Xiang Xue et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2008)
Balkan endemic nephropathy and associated urothelial cancer
Vladisav Stefanovic et al.
NATURE CLINICAL PRACTICE UROLOGY (2008)
Aristolochic acid mutagenesis:: molecular clues to the aetiology of Balkan endemic nephropathy-associated urothelial cancer
Volker M. Arlt et al.
CARCINOGENESIS (2007)
Role of environmental toxins in endemic (Balkan) nephropathy
Arthur P. Grollman et al.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2007)
New molecular and field evidences for the implication of mycotoxins but not aristolochic acid in human nephropathy and urinary tract tumor
Annie Pfohl-Leszkowicz et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2007)
Aristolochic acid and the etiology of endemic (Balkan) nephropathy
Arthur P. Grollman et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2007)
Selective toxicity of aristolochic acids I and II
Shinya Shibutani et al.
DRUG METABOLISM AND DISPOSITION (2007)
Renal transplantation in patients with Balkan endemic nephropathy
N. Basic-Jukic et al.
TRANSPLANTATION PROCEEDINGS (2007)
Investigation of the metabolism and reductive activation of carcinogenic aristolochic acids in rats
Wan Chan et al.
DRUG METABOLISM AND DISPOSITION (2007)
Evaluating nephrotoxicity of high-molecular-weight organic compounds in drinking water from lignite aquifers
Joseph E. Bunnell et al.
JOURNAL OF TOXICOLOGY AND ENVIRONMENTAL HEALTH-PART A-CURRENT ISSUES (2007)
Diagnostic criteria for Balkan endemic nephropathy: Proposal by an International panel
Vladisav Stefanovic et al.
RENAL FAILURE (2007)
Hemodialysis treatment in patients with Balkan endemic nephropathy: An epidemiological study
Rade Cukuranovic et al.
RENAL FAILURE (2007)
Evaluation of criteria for the diagnosis of Balkan endemic nephropathy
Ljubica Djukanovic et al.
RENAL FAILURE (2007)
Evaluation of the hypothesis that Balkan endemic nephropathy is caused by drinking water exposure to contaminants leaching from Pliocene coal deposits
Thomas C. Voice et al.
JOURNAL OF EXPOSURE SCIENCE AND ENVIRONMENTAL EPIDEMIOLOGY (2006)
Further studies with a cell immortalization assay to investigate the mutation signature of aristolochic acid in human p53 sequences
N. Feldmeyer et al.
MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS (2006)
Quantitative determination of aristolochic acid-derived DNA adducts in rats using 32P-postlabeling/polyacrylamide gel electrophoresis analysis
Huan Dong et al.
DRUG METABOLISM AND DISPOSITION (2006)
Balkan endemic nephropathy: Role of ochratoxins A through biomarkers
Marcel Castegnaro et al.
MOLECULAR NUTRITION & FOOD RESEARCH (2006)
Human sulphotransferases are involved in the activation of aristolochic acids and are expressed in renal target tissue
W Meinl et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Fifty years of Balkan endemic nephropathy: daunting questions, elusive answers
V Batuman
KIDNEY INTERNATIONAL (2006)
Clinical markers in adult offspring of families with and without Balkan Endemic Nephropathy
P Dimitrov et al.
KIDNEY INTERNATIONAL (2006)
Study of the phase I and phase II metabolism of nephrotoxin aristolochic acid by liquid chromatography/tandem mass spectrometry
Wan Chan et al.
RAPID COMMUNICATIONS IN MASS SPECTROMETRY (2006)
Etiology of Balkan endemic nephropathy and associated urothelial cancer
V Stefanovic et al.
AMERICAN JOURNAL OF NEPHROLOGY (2006)
The binding of aristolochic acid I to the active site of human cytochromes P450 1A1 and 1A2 explains their potential to reductively activate this human carcinogen
M Stiborová et al.
CANCER LETTERS (2005)
Recent data on endemic nephropathy and related urothelial tumors in Croatia
M Miletic-Medved et al.
WIENER KLINISCHE WOCHENSCHRIFT (2005)
Perspective: Ochratoxin A is not a genotoxic carcinogen
RJ Turesky
CHEMICAL RESEARCH IN TOXICOLOGY (2005)
A case for the genotoxicity of ochratoxin A by bioactivation and covalent DNA adduction
RA Manderville
CHEMICAL RESEARCH IN TOXICOLOGY (2005)
Genotype-phenotype associations of cytochrome P450 3A4 and 3A5 polymorphism with midazolam clearance in vivo
P He et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2005)
Genetic polymorphisms of cytochrome P450 among patients with Balkan endemic nephropathy (BEN)
SY Atanasova et al.
CLINICAL BIOCHEMISTRY (2005)
Human hepatic and renal microsomes, Cytochromes P450 1A1/2, NADPH:Cytochrome P450 reductase and prostaglandin H synthase mediate the formation of aristolochic acid-DNA adducts found in patients with urothelial cancer
M Stiborová et al.
INTERNATIONAL JOURNAL OF CANCER (2005)
DNA adduct formation by ochratoxin A: Review of the available evidence
A Mally et al.
FOOD ADDITIVES AND CONTAMINANTS PART A-CHEMISTRY ANALYSIS CONTROL EXPOSURE & RISK ASSESSMENT (2005)
Human tumor p53 mutations are selected for in mouse embryonic fibroblasts harboring a humanized p53 gene
ZP Liu et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Acute nephrotoxicity of aristolochic acids in mice
N Sato et al.
JOURNAL OF PHARMACY AND PHARMACOLOGY (2004)
Ochratoxin A:: Lack of formation of covalent DNA adducts
A Mally et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2004)
The induction of cytochrome P450 3A5 (CYP3A5) in the human liver and intestine is mediated by the xenobiotic sensors pregnane X receptor (PXR) and constitutively activated receptor (CAR)
O Burk et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2004)
Multicentric Castleman's disease associated with glomerular microangiopathy and MPGN-like lesion: Does vascular endothelial cell-derived growth factor play causative or protective roles in renal injury?
A Seida et al.
AMERICAN JOURNAL OF KIDNEY DISEASES (2004)
Aristolochic acid (AA)-DNA adduct as marker of AA exposure and risk factor for AA nephropathy-associated cancer
VM Arlt et al.
INTERNATIONAL JOURNAL OF CANCER (2004)
Quinone reductases multitasking in the metabolic world
D Ross
DRUG METABOLISM REVIEWS (2004)
Human cytosolic enzymes involved in the metabolic activation of carcinogenic aristolochic acid:: evidence for reductive activation by human NAD(P)H:quinone oxidoreductase
M Stiborová et al.
CARCINOGENESIS (2003)
Aristolochic acid and 'Chinese herbs nephropathy' - A review of the evidence to date
JP Cosyns
DRUG SAFETY (2003)
Aristolochic acid a risk factor for Balkan endemic nephropathy-associated urothelial cancer?
VM Arlt et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
Aristolochic acid as a probable human cancer hazard in herbal remedies: a review
VM Arlt et al.
MUTAGENESIS (2002)
Carcinogenic aristolochic acids upon activation by DT-diaphorase form adducts found in DNA of patients with Chinese herbs nephropathy
M Stiborová et al.
CARCINOGENESIS (2002)
Metabolism and lack of DNA reactivity of the mycotoxin ochratoxin A in cultured rat and human primary hepatocytes
K Gross-Steinmeyer et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2002)
Progression rate of Chinese herb nephropathy: impact of Aristolochia fangchi ingested dose
MCM Martinez et al.
NEPHROLOGY DIALYSIS TRANSPLANTATION (2002)
Balkan endemic nephropathy and associated urinary tract tumours: a review on aetiological causes and the potential role of mycotoxins
A Pfohl-Leszkowicz et al.
FOOD ADDITIVES AND CONTAMINANTS PART A-CHEMISTRY ANALYSIS CONTROL EXPOSURE & RISK ASSESSMENT (2002)
Urothelial malignant disease and Chinese herbal nephropathy
GM Lord et al.
LANCET (2001)
Human enzymes involved in the metabolic activation of carcinogenic aristolochic acids:: Evidence for reductive activation by cytochromes P450 1A1 and 1A2
M Stiborová et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2001)
Analyses of DNA adducts formed by ochratoxin A and aristolochic acid in patients with Chinese herbs nephropathy
VM Arlt et al.
MUTATION RESEARCH-GENETIC TOXICOLOGY AND ENVIRONMENTAL MUTAGENESIS (2001)
Isolation of DT-diaphorase [NAD(P)H dehydrogenase (quinone)] from rat liver cytosol:: Identification of new enzyme substrates, carcinogenic aristolochic acids
M Stiborova et al.
COLLECTION OF CZECHOSLOVAK CHEMICAL COMMUNICATIONS (2001)
Metabolism of ochratoxin A: Absence of formation of genotoxic derivatives by human and rat enzymes
JC Gautier et al.
CHEMICAL RESEARCH IN TOXICOLOGY (2001)
NAD(P)H:quinone oxidoreductase 1 (NQO1):: chemoprotection, bioactivation, gene regulation and genetic polymorphisms
D Ross et al.
CHEMICO-BIOLOGICAL INTERACTIONS (2000)
Regulation of genes encoding NAD(P)H:quinone oxidoreductases
AK Jaiswal
FREE RADICAL BIOLOGY AND MEDICINE (2000)
Urothelial carcinoma associated with the use of a Chinese herb (Aristolochia fangchi).
JL Nortier et al.
NEW ENGLAND JOURNAL OF MEDICINE (2000)
Role of the aromatic hydrocarbon receptor and [Ah] gene battery in the oxidative stress response, cell cycle control, and apoptosis
DW Nebert et al.
BIOCHEMICAL PHARMACOLOGY (2000)
Share Paper
